| Literature DB >> 29775962 |
Agnès Martin1, Camille Faes2, Tadej Debevec3, Chantal Rytz4, Grégoire Millet5, Vincent Pialoux6.
Abstract
Preterm birth is a global health issue that can induce lifelong medical sequela. Presently, at least one in ten newborns are born prematurely. At birth, preterm newborns exhibit higher levels of oxidative stress (OS) due to the inability to face the oxygen rich environment in which they are born into. Moreover, their immature respiratory, digestive, immune and antioxidant defense systems, as well as the potential numerous medical interventions following a preterm birth, such as oxygen resuscitation, nutrition, phototherapy and blood transfusion further contribute to high levels of OS. Although the acute effects seem well established, little is known regarding the long-term effects of preterm birth on OS. This matter is especially important given that chronically elevated OS levels may persist into adulthood and consequently contribute to the development of numerous non-communicable diseases observed in people born preterm such as diabetes, hypertension or lung disorders. The purpose of this review is to summarize the current knowledge regarding the consequences of preterm birth on OS levels from newborn to adulthood. In addition, the effects of physical activity and hypoxia, both known to disrupt redox balance, on OS modulation in preterm individuals are also explored.Entities:
Keywords: Antioxidants; Hypoxia; Physical exercise; Prematurity; Reactive oxygen species
Mesh:
Substances:
Year: 2018 PMID: 29775962 PMCID: PMC6006904 DOI: 10.1016/j.redox.2018.04.022
Source DB: PubMed Journal: Redox Biol ISSN: 2213-2317 Impact factor: 11.799
Levels of various OS markers and antioxidants at birth in preterm newborns.
| 10/10 | 40.4 (38–40.9) | 33.1 (32.9–35.7) | Erythrocytes / umbilical cord blood | at birth | No intensive care requirement and medical complications | ↑ hydroperoxides | ↓ vitamin E | ||
| ↓ SOD | |||||||||
| ↓ GPx | |||||||||
| 116/124 | 38 (NA) | 34.7 (NA) | Umbilical cord blood | at birth | All were LBW and 51 were SGA | ↑ protein carbonyl | ↓ vitamin A | SGA PTB: ↑ protein carbonyl, ↑ MDA, ↓ vitamin A, ↓ vitamin C, ↓ vitamin E, ↓ TAS | |
| No infection, hemolytic disease, hypertensive disorder, major malformations, history of difficult delivery, genetic disorder or fetal distress. | |||||||||
| ↓ vitamin C | |||||||||
| ↑ MDA | |||||||||
| ↓ vitamin E | |||||||||
| ↓ TAS | |||||||||
| 100/100 | 38 (37–40) | 31 (27–34) | Umbilical cord blood | at birth | No SGA newborns. | ↑ MDA | ↓ vitamin A | PTB with NEC: ↓vitamin A, ↑vitamin E, ↓CAT | |
| 10 suffered from NEC, 20 from BPD, 24 from IVH and 28 did not survived. | |||||||||
| PTB with BPD: ↓vitaminA, ↑ vitamin E, ↓ TAS, ↓ CAT, ↑ MDA | |||||||||
| No gestational diabetes. No major congenital anomalies and no death within the first week. | |||||||||
| ↓ vitamin E | |||||||||
| ↓ TAS | |||||||||
| PTB with IVH: | |||||||||
| ↓ vitamin A, ↓ TAS, ↓ CAT, ↑ MDA | |||||||||
| ↓ CAT | |||||||||
| Parenteral nutrition begun for all within 24–48 h of life. | |||||||||
| PTB with death: | |||||||||
| ↑ MDA | |||||||||
| 179/21 | NA | NA | Umbilical cord blood | at birth | Healthy mothers without diabetes | ↑ protein carbonyl | ↓ vitamin A = vitamin E | ||
| = 3 nitrotyrosine | |||||||||
| = MDA | |||||||||
| 25/33 | (38–42) | (24–36) | Umbilical cord blood | at birth | NA | ↑ vitamin C | |||
| 24/22 | 40.1 (NA) | 32.2 (NA) | Umbilical cord blood | at birth | No SGA. | ↑ NPBI | ↓ transferrin | ||
| No hemolytic disease. | |||||||||
| 41% required respiratory support | |||||||||
| 32/32 | NA | NA | Umbilical cord blood | at birth | Born from mothers without history of diabetes mellitus, gestational diabetes or smoking. Fetal distress was not the cause of prematurity | ↑ MDA | ↓ SOD | ||
| ↓ GSH | |||||||||
| 9/15 | 39.2 (38–40) | 32.3 (29–34) | Umbilical cord blood | at birth | Good condition, only one were not breathing spontaneously by | ↓ SOD | |||
| 5 min of age, all were breathing room air by 24 h, no supplementary | |||||||||
| Oxygen requirements, no evidence of perinatal | |||||||||
| Hypoxia or episodes of proven sepsis | |||||||||
| 24/55 | 38 (NA) | 34.2 (NA) | Umbilical cord blood | at birth | All were LBW. | ↑ MDA | ↓ TAS | MDA and 8-OHdG correlate negatively with birth weight | |
| Mothers without eclampsia or hypertension. No intrauterine growth retardation, perinatal asphyxia, infection, hemolytic disease, major malformations, difficult delivery, genetic disorder or fetal distress. | |||||||||
| ↑ 8-OHdG | |||||||||
| 27/24 | 38.1 (37–41) | 33.7 (30–36) | Umbilical cord blood | at birth | NA | ↑ plasma F2-isoprostane | |||
| ↑ NPBI | |||||||||
| ↑ DCI | |||||||||
| ↑ placenta F2-isoprostane | |||||||||
| 91/47 | 39.2 (36–42) | 31.4 (23–36) | Umbilical cord blood | at birth | 32 required assisted ventilation, 22 suffered from respiratory distress syndrome and 10 from perinatal hypoxia | ↑ MDA | |||
| 29/31 | 39.4 (37.4–41.6) | 31.7 (28.1–35.7) | Umbilical cord blood | at birth | No SGA newborns. | ↑ MDA adduct to hemoglobin | |||
| No intensive care requirement and medical complications | |||||||||
| 25/25 | 38.04 (36–42) | 32.92 (28–35) | Umbilical cord blood | at birth | No congenital malformations or asphyxia. | = MDA | = TAS | ||
| = CAT | |||||||||
| Healthy nonsmokers’ mothers. | ↓ SOD | ||||||||
| 30/40 | NA (37–42) | NA (24–36) | Umbilical cord blood | at birth | Healthy nonsmokers mothers | ↑ lipid peroxidation | ↑ vitamin C |
8-OHdG: 8-hydroxy-2-deoxy guanosine; BPD: bronchopulmonary dysplasia; CAT: catalase; DCI: erythrocyte chelatable iron; GA: gestational age; GPx: glutathione peroxidase; GSH: reduced glutathione; IVH: intraventricular hemorrhage; LBW: low birth weight (< 2500 g at birth); MDA: malondialdehyde; NA: not available; NEC: necrotizing enterocolitis; NPBI: Non-protein-bound iron; PTB: preterm birth; SGA: small for GA; SOD: superoxide dismutase; TAS: total antioxidant status; ↓ significantly decreased compared to term newborns; ↑ significantly increased compared to term newborns; = no significantly variation compared to term newborns. aexpressed in week as mean (minimum-maximum).
Fig. 1The chicken and egg paradigm of oxidative stress in preterm from birth to adulthood. PTB increases the risk to develop of several diseases at birth up to adulthood. The higher oxidative stress during the life of PTB could have a role in the pathogenesis of these diseases but could be induced by these diseases. PTB: preterm birth, ROS: reactive oxygen species.
Studies investigating the acute and prolonged effects of environmental hypoxia on oxidative stress and antioxidant markers in humans.
| 13-day HH @ 4300 m | ↑ LPO | ↑ α-tocopherol | Prolonged HH exposure augments oxidative stress. | |
| Healthy active individuals (N = 18) | ↓ 8-OHdG | ↑ β-carotene | ||
| 4-h HH @ 5500 m | ↑ GSSG (%) | ↓ TGSH | Acute HH exposure augments oxidative stress. | |
| Healthy active individuals (N=6) | ↑ TBARS | |||
| 10-min exercise in NH @ 4800 m & | ↑ MDA | ↓ FRAP (3000 m test only) | Even high antioxidant capacity of elite athletes does not counteract acute NH-induced oxidative stress. | |
| 3-hour NH @ 3000 m | ||||
| Elite athletes (N=41) | ↑ AOPP | ↓ α-tocopherol | ||
| 24-h NH & HH @ 3000 m | ↑ AOPP (higher in HH) | ↑ SOD (only in HH) | HH induces higher oxidative stress level as compared to NH. | |
| Healthy trained individuals (N=10) | ||||
| 10-day NH @ 4000 m | ↑AOPP | ↑ GPx | NH | |
| Healthy active individuals (N=6) | ↑ Nitrotyrosine | |||
| 10-h NH & HH @ 3450 m | ↑ AOPP | ↑ GPx (HH only) | HH provokes greater prooxidant/antioxidant imbalance than NH. | |
| Healthy trained individuals (N=16) | ↑ SOD (HH only) | |||
| ↓ FRAP | ||||
| ↓ UA | ||||
| 10-day NH exposure @ 4000 m during bed rest | ↑ AOPP | ↑ Catalase | NH exposure augments inactivity-related oxidative stress. | |
| ↓ GPx | ||||
| Healthy active females (N=12) |
HH: Hypobaric hypoxia; NH: Normobaric hypoxia; ↓: significantly decreased; ↑: significantly increased; LPO: Lipid hydroperoxides; 8-OHdG: 8-hydroxydeoxyguanosine; GSSG (%): oxidized glutathione percentage, TBARS: Thiobarbituric acid reactive substances, TGSH: total glutathione content; MDA: malondialdehyde; AOPP: advanced oxidation protein products; FRAP: ferric-reducing antioxidant power; SOD: superoxide dismutase; GPx: glutathione peroxidase; UA: Uric acid.